Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-630
Closed -$222K 128
2026
Q1
$222K Sell
630
-15
-2% -$5.35K 0.1% 111
2025
Q4
$211K Buy
+645
New +$205K 0.09% 115
2025
Q2
Sell
-645
Closed -$201K 115
2025
Q1
$201K Buy
+645
New +$190K 0.1% 102
2024
Q4
Sell
-645
Closed -$208K 111
2024
Q3
$208K Hold
645
0.12% 112
2024
Q2
$202K Buy
+645
New +$189K 0.12% 103

Other funds holding AMGN

626 Financial's AMGN Position: Q2 2026 in Review

626 Financial sold out of Amgen (AMGN) in Q2 2026, closing a stake of 630 shares — an estimated $222K sold.

626 Financial first reported a position in AMGN in Q2 2024 and held it in 5 quarters. The position peaked at $222K in Q1 2026. 1,984 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • 626 Financial reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • 626 Financial sold 630 Amgen shares in Q2 2026, an estimated $222K.
  • 626 Financial first reported a position in Amgen in Q2 2024 and held it in 5 quarters.
  • 626 Financial's Amgen position peaked at $222K in Q1 2026.
  • 1,984 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on 626 Financial's 13F filing for Q2 2026, filed 27 Jul 2026.